These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 2493514

  • 1. Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2.
    Ostensen ME, Thiele DL, Lipsky PE.
    J Biol Response Mod; 1989 Feb; 8(1):53-61. PubMed ID: 2493514
    [Abstract] [Full Text] [Related]

  • 2. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA, Custer MC, Rosenberg SA, Lotze MT.
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
    Ostensen ME, Thiele DL, Lipsky PE.
    J Immunol; 1987 Jun 15; 138(12):4185-91. PubMed ID: 3108384
    [Abstract] [Full Text] [Related]

  • 4. Studies on the natural killer cell activity of human nonadherent mononuclear cells (nMNC) with tumor necrosis factor, interleukin-1, interferon-gamma and cisplatin.
    Pai K, Sodhi A.
    Neoplasma; 1992 Jun 15; 39(6):363-7. PubMed ID: 1491726
    [Abstract] [Full Text] [Related]

  • 5. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro.
    Ghoneum M, Jewett A.
    Cancer Detect Prev; 2000 Jun 15; 24(4):314-24. PubMed ID: 11059563
    [Abstract] [Full Text] [Related]

  • 6. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR, Kamber M, Peck R.
    Lymphokine Res; 1987 Jun 15; 6(3):215-27. PubMed ID: 3114569
    [Abstract] [Full Text] [Related]

  • 7. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K, Urawa H, Tamatani T, Iwamura Y, Hashimoto T, Baba T, Suzuki H, Yamada M, Yamamoto S, Oppenheim JJ.
    J Immunol; 1988 Jan 01; 140(1):112-9. PubMed ID: 3275716
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
    Morikawa K, Fidler IJ.
    J Biol Response Mod; 1989 Apr 01; 8(2):206-18. PubMed ID: 2499665
    [Abstract] [Full Text] [Related]

  • 9. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
    Owen-Schaub LB, Gutterman JU, Grimm EA.
    Cancer Res; 1988 Feb 15; 48(4):788-92. PubMed ID: 3257408
    [Abstract] [Full Text] [Related]

  • 10. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM, Vilcek J.
    J Immunol; 1987 Nov 15; 139(10):3330-7. PubMed ID: 3119705
    [Abstract] [Full Text] [Related]

  • 11. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ, Cameron C, Lazo S, Cochran KJ, Voss SD, Ritz J.
    Nat Immun; 1987 Nov 15; 15(5):213-26. PubMed ID: 9390270
    [Abstract] [Full Text] [Related]

  • 12. TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2.
    Favrot M, Combaret V, Blay JY, Capdeville R, Zhou DC, Clapisson G, Chouaib S, Franks CR, Philip T.
    Eur Cytokine Netw; 1990 Nov 15; 1(4):221-7. PubMed ID: 2104243
    [Abstract] [Full Text] [Related]

  • 13. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM, Ortaldo JR, Shalaby MR, Svedersky LP, Nedwin GE, Bringman TS, Hass PE, Aggarwal BB, Herberman RB, Goeddel DV.
    J Immunol; 1986 Oct 15; 137(8):2592-8. PubMed ID: 3760569
    [Abstract] [Full Text] [Related]

  • 14. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells.
    Aste-Amezaga M, D'Andrea A, Kubin M, Trinchieri G.
    Cell Immunol; 1994 Jul 15; 156(2):480-92. PubMed ID: 7912999
    [Abstract] [Full Text] [Related]

  • 15. Costimulatory signals are required for optimal proliferation of human natural killer cells.
    Robertson MJ, Manley TJ, Donahue C, Levine H, Ritz J.
    J Immunol; 1993 Mar 01; 150(5):1705-14. PubMed ID: 7679691
    [Abstract] [Full Text] [Related]

  • 16. Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin 1 alpha, interleukin 1 beta, and tumor necrosis factor.
    Beresini MH, Lempert MJ, Epstein LB.
    J Immunol; 1988 Jan 15; 140(2):485-93. PubMed ID: 3121746
    [Abstract] [Full Text] [Related]

  • 17. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
    Hoon DS, Banez M, Okun E, Morton DL, Irie RF.
    Cancer Res; 1991 Apr 15; 51(8):2002-8. PubMed ID: 1901239
    [Abstract] [Full Text] [Related]

  • 18. Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake.
    Laso FJ, Lapeña P, Madruga JI, San Miguel JF, Orfao A, Iglesias MC, Alvarez-Mon M.
    Alcohol Clin Exp Res; 1997 Oct 15; 21(7):1226-31. PubMed ID: 9347083
    [Abstract] [Full Text] [Related]

  • 19. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ, Ronteltap CP, Gravekamp C, Monnikendam D, Bolhuis RL.
    J Immunol; 1986 Mar 01; 136(5):1700-7. PubMed ID: 3005399
    [Abstract] [Full Text] [Related]

  • 20. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
    Hori K, Mihich E, Ehrke MJ.
    Cancer Res; 1989 May 15; 49(10):2606-14. PubMed ID: 2496917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.